Concepedia

Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes

K. Fujimoto, Yoshiyuki Hamamoto, Sachiko Honjo, Yukiko Kawasaki, Kanako Mori, Hisato Tatsuoka, Atsuko Matsuoka, Yoshiharu Wada, Hiroki Ikeda, Jun Fujikawa,

Diabetes Research and Clinical Practice · 2012 · 34 citations · 7 references

DOI

Concepts

References

7

Global cancer statistics

Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text

, , +15

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

, , +15

Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity

Stephen C. Benson, Harrihar A. Pershadsingh, Christopher Ho et al. · Hypertension · 2004 · 1.1K citations

, , +17

Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone

James D. Lewis, Assiamira Ferrara, Tiffany Peng et al. · Diabetes Care · 2011 · 621 citations · Full text

, , +13

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

Anke Neumann, Alain Weill, P. Ricordeau et al. · Diabetologia · 2012 · 279 citations · Full text

, , +12